(Press-News.org) A simple point-of-care testing device for anemia could provide more rapid diagnosis of the common blood disorder and allow inexpensive at-home self-monitoring of persons with chronic forms of the disease.
The disposable self-testing device analyzes a single droplet of blood using a chemical reagent that produces visible color changes corresponding to different levels of anemia. The basic test produces results in about 60 seconds and requires no electrical power. A companion smartphone application can automatically correlate the visual results to specific blood hemoglobin levels.
By allowing rapid diagnosis and more convenient monitoring of patients with chronic anemia, the device could help patients receive treatment before the disease becomes severe, potentially heading off emergency room visits and hospitalizations. Anemia, which affects two billion people worldwide, is now diagnosed and monitored using blood tests done with costly test equipment maintained in hospitals, clinics or commercial laboratories.
Because of its simplicity and ability to deliver results without electricity, the device could also be used in resource-poor nations.
A paper describing the device and comparing its sensitivity to gold-standard anemia testing was published August 30 in The Journal of Clinical Investigation. Development of the test has been supported by the FDA-funded Atlantic Pediatric Device Consortium, the Georgia Research Alliance, Children's Healthcare of Atlanta, the Georgia Center of Innovation for Manufacturing and the Global Center for Medical Innovation.
"Our goal is to get this device into patients' hands so they can diagnose and monitor anemia themselves," said Dr. Wilbur Lam, senior author of the paper and a physician in the Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta and the Department of Pediatrics at the Emory University School of Medicine.
"Patients could use this device in a way that's very similar to how diabetics use glucose-monitoring devices, but this will be even simpler because this is a visual-based test that doesn't require an additional electrical device to analyze the results."
The test device was developed in a collaboration of Emory University, Children's Healthcare of Atlanta and the Georgia Institute of Technology – all based in Atlanta. It grew out of a 2011 undergraduate senior design project in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. In 2013, it was among the winners of Georgia Tech's InVenture Prize, an innovation competition for undergraduate students, and won first place in the Ideas to SERVE Competition in Georgia Tech's Scheller College of Business.
Using a two-piece prototype device, the test works this way: A patient sticks a finger with a lance similar to those used by diabetics to produce a droplet of blood. The device's cap, a small vial, is then touched to the droplet, drawing in a precise amount of blood using capillary action. The cap containing the blood sample is then placed onto the body of the clear plastic test kit, which contains the chemical reagent. After the cap is closed, the device is briefly shaken to mix the blood and reagent.
"When the capillary is filled, we have a very precise volume of blood, about five microliters, which is less than a droplet – much less than what is required by other anemia tests," explained Erika Tyburski, the paper's first author and leader of the undergraduate team that developed the device.
Blood hemoglobin then serves as a catalyst for a reduction-oxidation reaction that takes place in the device. After about 45 seconds, the reaction is complete and the patient sees a color ranging from green-blue to red, indicating the degree of anemia.
A label on the device helps with interpretation of the color, or the device could be photographed with a smartphone running an application written by Georgia Tech undergraduate student Alex Weiss and graduate student William Stoy. The app automatically correlates the color to a specific hemoglobin level, and could one day be used to report the data to a physician.
To evaluate sensitivity and specificity of the device, Tyburski studied blood taken from 238 patients, some of them children at Children's Healthcare of Atlanta and the others adults at Emory University's Winship Cancer Institute. Each blood sample was tested four times using the device, and the results were compared to reports provided by conventional hematology analyzers.
The work showed that the results of the one-minute test were consistent with those of the conventional analysis. The smartphone app produced the best results for measuring severe anemia.
"The test doesn't require a skilled technician or a draw of venous blood and you see the results immediately," said Lam, who is also an assistant professor in the Coulter Department of Biomedical Engineering. "We think this is an empowering system, both for the general public and for our patients."
Tyburski and Lam have teamed up with two other partners and worked with Emory's Office of Technology Transfer to launch a startup company, Sanguina, to commercialize the test, which will be known as AnemoCheck™. The test ultimately will require approval from the FDA. The team also plans to study how the test may be applied to specific diseases, such as sickle cell anemia – which is common in Georgia.
The device could be on pharmacy shelves sometime in 2016, where it might help people like Tyburski, who has suffered mild anemia most of her life. "If I'd had this when I was kid, I could have avoided some trips to the emergency room when I passed out in gym class," she said.
About a third of the population is at risk for anemia, which can cause neurocognitive deficits in children, organ failure and less serious effects such as chronic fatigue. Women, children, the elderly and those with chronic conditions such as kidney disease are more likely to suffer from anemia.
INFORMATION: END
One-minute point-of-care anemia test shows promise in new study
2014-09-11
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Meditation may mitigate migraine misery
2014-09-11
WINSTON-SALEM, N.C. – Sept. 11, 2014 – Meditation might be a path to migraine relief, according to a new study by researchers at Wake Forest Baptist Medical Center.
"Stress is a well-known trigger for headaches and research supports the general benefits of mind/body interventions for migraines, but there hasn't been much research to evaluate specific standardized meditation interventions," said Rebecca Erwin Wells, M.D., assistant professor of neurology at Wake Forest Baptist and lead author of the study published in the online edition of the journal Headache.
The study ...
Yogic breathing shows promise in reducing symptoms of post-traumatic stress disorder
2014-09-11
MADISON, Wis. — One of the greatest casualties of war is its lasting effect on the minds of soldiers. This presents a daunting public health problem: More than 20 percent of veterans returning from the wars in Iraq and Afghanistan have post-traumatic stress disorder, according to a 2012 report by RAND Corp.
A new study from the Center for Investigating Healthy Minds at the Waisman Center of the University of Wisconsin-Madison offers hope for those suffering from the disorder. Researchers there have shown that a breathing-based meditation practice called Sudarshan Kriya ...
Volunteer 'eyes on the skies' track peregrine falcon recovery in California
2014-09-11
In recovery from the deadly legacy of DDT, American peregrine falcons (Falco peregrines anatum) faced new uncertainty in 1992, when biologists proposed to stop rearing young birds in captivity and placing them in wild nests. Tim Wootton and Doug Bell published models that year in ESA's journal Ecological Applications, projecting population trends for the falcon in California, with and without direct human intervention in the falcons' reproductive lives. They concluded that the birds would continue to recover without captive rearing, though the population growth rate might ...
NASA research gives guideline for future alien life search
2014-09-11
Astronomers searching the atmospheres of alien worlds for gases that might be produced by life can't rely on the detection of just one type, such as oxygen, ozone, or methane, because in some cases these gases can be produced non-biologically, according to extensive simulations by researchers in the NASA Astrobiology Institute's Virtual Planetary Laboratory.
The researchers carefully simulated the atmospheric chemistry of alien worlds devoid of life thousands of times over a period of more than four years, varying the atmospheric compositions and star types. "When we ...
Few mild-to-moderate Parkinson's disease patients suffer from malnutrition, yet almost one-third are at risk
2014-09-11
Amsterdam, NL, 11 September 2014 – Patients with Parkinson's disease (PD) can experience difficulties with food preparation and ingestion, which could contribute to poor nutrition and place them at risk for malnourishment. Published studies have also suggested that PD is associated with low weight, however, few studies included control groups. A report published in the Journal of Parkinson's Disease counters this conclusion in patients with mild-to-moderate PD, finding that the incidence or risk of malnutrition is no different for patients with mild-to-moderate PD compared ...
African American women receive less breast reconstruction after mastectomy
2014-09-11
Dartmouth researchers have found that African American women are 55 percent less likely to receive breast reconstruction after mastectomy regardless of where they received their care. They report on their findings in "The influence of race/ethnicity and place of service on breast reconstruction for Medicare beneficiaries with mastectomy," recently published in SpringerPlus.
"We wanted to understand whether the racial disparity observed in breast reconstruction among women with breast cancer was related to where women received care, independent of race," said Tracy Onega, ...
Commensal bacteria help orchestrate immune response in lung
2014-09-11
Studies in mice demonstrate that signals from the bacteria that harmlessly—and often beneficially—inhabit the human gastrointestinal tract boost the immune system's ability to kill a major respiratory pathogen, Klebsiella pneumoniae, according to a paper published online ahead of print in the journal Infection and Immunity.
The research is yet another example of how important these "commensal" bacteria are to human health and physiology, says Thomas B. Clarke, of Imperial College London, UK, the lone author of this paper.
"Numerous studies have shown that changes ...
Researchers make scientific history with new cellular connection
2014-09-11
Researchers led by Dr. Helen McNeill at the Lunenfeld-Tanenbaum Research Institute have revealed an exciting and unusual biochemical connection. Their discovery has implications for diseases linked to mitochondria, which are the primary sources of energy production within our cells.
Dr. McNeill's team has an international reputation for their work in understanding how cells become organized into tissues and how growth is regulated during development. The group focuses on mutations in the fat (ft) gene. The protein product of this gene, called 'Fat', acts at the cell membrane ...
Primary care doctors reluctant to provide genetics assessment in routine care
2014-09-11
Ann Arbor, Mich. — Primary care providers report many challenges to integrating genetics services into routine primary care, according to research published today in Genetics in Medicine.
Medical genetics medicine has traditionally been used to identify and diagnose rare diseases, but in the last decade it has been increasingly helpful in determining patients at risk for genetically-based conditions who can benefit from preventive health care, says the study's senior author, Beth Tarini, M.D., M.S., F.A.A.P., assistant professor of pediatrics at the University of Michigan ...
Penn medicine study reveals profile of patients most likely to delay hospice enrollment
2014-09-11
One in six cancer patients enroll in hospice only during their last three days of life, according to a new study from a team from the Perelman School of Medicine at the University of Pennsylvania. Their findings, published online last month in the Journal of Clinical Oncology (JCO) also reveal a profile of patients who may be most at risk of these late admissions.
"Waiting until the final days of life to begin hospice can shortchange patients and their families – skipping over many benefits of hospice care and limiting the opportunity to improve patients' quality of ...